Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[ASCUS: an update].

J-C Boulanger1, H Sevestre

  • 1Centre de gynécologie-obstétrique (CGO), CHU d'Amiens, 124, rue Camille-Desmoulins, 80054 Amiens cedex 01, France. boulanger.jean-charles@chu-amiens.fr

Gynecologie, Obstetrique & Fertilite
|January 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency.

Case reports in critical care·2020
Same author

A case of Erdheim-Chester disease with spinal cord compression and sphenoid sinus involvement.

Neuro-Chirurgie·2018
Same author

[Bone epithelioid hemangioendotheliom].

La Revue de medecine interne·2018
Same author

[Actinomycosis revealed by ulceration of the palate and gingiva].

Annales de dermatologie et de venereologie·2017
Same author

Impact of anaesthesia mode on evaluation of LEEP specimen dimensions.

Journal of gynecology obstetrics and human reproduction·2017
Same author

Management of presumed benign ovarian tumors: updated French guidelines.

European journal of obstetrics, gynecology, and reproductive biology·2014
Same journal

[Lucy's cancer(s): A prehistorical origin?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Male age in assisted reproductive technologies: Is there a limit?]

Gynecologie, obstetrique & fertilite·2016
Same journal

[Iodinated contrast in pregnant women and neonatal thyroid function].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Breast cancer and diabetes mellitus: Complex interactions].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Why and how to perform an ultrasound-guided transversus abdominis plane block: A step-by-step approach].

Gynecologie, obstetrique & fertilite·2016
Same journal

[Does post operative sonographic position of preventive cervical cerclage affect gestational age at birth?]

Gynecologie, obstetrique & fertilite·2016
See all related articles

Managing atypical squamous cells of undetermined significance (ASCUS) in cervical cytology can be challenging due to its wide range of potential causes. This review offers updated guidelines for handling ASC-US and ASC-H diagnoses.

Area of Science:

  • Gynecologic pathology
  • Cervical cytology
  • Cytopathology reporting systems

Context:

  • Atypical squamous cells of undetermined significance (ASCUS) in cervical cytology presents diagnostic challenges for clinicians.
  • The histological correlation for ASCUS ranges from normal cervical mucosa to invasive carcinoma, often stemming from benign reactive changes.
  • The Bethesda System for Reporting Cervical Cytology has evolved, with ASCUS subcategorized into ASC-US and ASC-H in 2001.

Purpose:

  • To provide updated clinical management guidelines for ASC-US and ASC-H diagnoses.
  • To clarify the diagnostic spectrum and implications of ASCUS findings.
  • To improve the link between cervical cytology reporting and lesional diagnosis.

Summary:

  • ASCUS diagnoses require careful management due to their broad differential diagnosis.

Related Experiment Videos

  • The subcategorization of ASC into ASC-US (atypical squamous cells of undetermined significance) and ASC-H (atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion) aims to refine diagnostic accuracy.
  • This review synthesizes current knowledge to guide clinicians in managing these specific cytological findings.

    • Impact:

    • Facilitates more precise patient management based on ASCUS subcategorization.
    • Aims to reduce unnecessary procedures for benign conditions while ensuring timely diagnosis of significant lesions.
    • Contributes to the standardization of cervical cancer screening protocols.